Indaptus Therapeutics, Inc. (INDP) stock

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$3.17+0.02 (+0.63%)

Close on Nov 13, 2026Market cap $422.38MP/E –Yield –

Indaptus Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Indaptus Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?